Skip to main content Accessibility help
×
Home

What do we know about treatment-resistant schizophrenia? – A systematic review

  • A. Seppälä (a1), J. Miettunen (a1), N. Hirvonen (a2), M. Isohanni (a3), J. Moilanen (a3), H. Koponen (a4), J. Seppälä (a5) and E. Jääskeläinen (a1)...

Abstract

Introduction

Treatment-resistant schizophrenia (TRS) is a severe form of schizophrenia. From one fifth to one third of all patients with schizophrenia are resistant to treatment.

Objective

To determine the knowledge on TRS and to find out the extent and the quality of research on TRS.

Aims

To conduct a systematic review of the current literature on TRS.

Methods

Original studies and reviews on TRS were systematically collected from PubMed and Scopus databases. The following search strategy was used as a title search; (“ultra-resistant” OR “treatment-refractory” OR “treatment-resistant”) AND (schizophrenia). The search was restricted to English language articles.

Results

The literature search identified 403 studies. After abstract and title review, 324 studies were included. The included studies considered medication (n 213), electroconvulsive therapy and repetitive transcranial magnetic stimulation (15), prognosis (15), genetics (15), studies on neurobiology (15), definitions (14), psychotherapy (12), brain structures and functioning (10), cognition (7) and other miscellaneous studies (6) on TRS. Definitions of TRS varied notably and in most of the non-pharmacological studies, the samples were fairly small. Regarding treatments, clozapine, ECT, and cognitive-behavioral therapy have shown effectiveness, though the quality of research on interventions is limited. Very little is known about risk factors and predictors of outcome in TRS.

Conclusions

Our findings suggest TRS is poorly studied and understood condition contrasted to its high prevalence, clinical importance and poor prognosis. There is a lack of studies on epidemiology, for example risk factors of TRS, as well as on outcomes and longitudinal course. Most of the studies considered medication.

Disclosure of interest

The authors have not supplied their declaration of competing interest.

Copyright

Corresponding author

*Corresponding author.

What do we know about treatment-resistant schizophrenia? – A systematic review

  • A. Seppälä (a1), J. Miettunen (a1), N. Hirvonen (a2), M. Isohanni (a3), J. Moilanen (a3), H. Koponen (a4), J. Seppälä (a5) and E. Jääskeläinen (a1)...

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.

What do we know about treatment-resistant schizophrenia? – A systematic review

  • A. Seppälä (a1), J. Miettunen (a1), N. Hirvonen (a2), M. Isohanni (a3), J. Moilanen (a3), H. Koponen (a4), J. Seppälä (a5) and E. Jääskeläinen (a1)...
Submit a response

Comments

No Comments have been published for this article.

×

Reply to: Submit a response


Your details


Conflicting interests

Do you have any conflicting interests? *